Borrell: Russia Not Invited to Syria Brussels Conference Because of Aggression on Ukraine

EU foreign policy chief Josep Borrell. AFP
EU foreign policy chief Josep Borrell. AFP
TT

Borrell: Russia Not Invited to Syria Brussels Conference Because of Aggression on Ukraine

EU foreign policy chief Josep Borrell. AFP
EU foreign policy chief Josep Borrell. AFP

EU foreign policy chief Josep Borrell told Asharq Al-Awsat in an interview that the European Union holds onto its three “red lines” which involve not contributing to Syria’s reconstruction, not removing sanctions and not re-establishing full diplomatic ties with Damascus “until a genuine and comprehensive political transition is firmly under way in accordance with UN Security Council Resolution 2254.”

“The EU policy positions have not changed since the behavior of the Assad regime is not changing,” said Borrell, adding that the EU continues to help Syrians inside and outside the country. “Since the beginning of the Syrian conflict in 2011, the European Union and its Member States have been the largest donors of humanitarian and resilience assistance to Syria and the region with € 27.4 billion.”

Borrell spoke on the eve of the two-day donor conference that is set to be held in Brussels on Monday.

“This conference is traditionally the main pledging event of the year for the Syrian people. What is different this year is that it takes place on the backdrop of an unprecedented military aggression directly in EU’s neighborhood. But we want to show to Syrian people that despite the Russian aggression against Ukraine, we remain committed to continue supporting also the Syrian people and host communities in neighboring countries, and we are not forgetting them,” he said.

Borrell confirmed that Russia was not invited to the conference.

“We are inviting those partners who have a genuine interest to contribute to peace in the world and to help victims of conflict. Through its aggression on Ukraine, Russia has proven that it is not sharing this interest,” he said.

Here is the full text of the interview carried out on Saturday.

1- What do you expect of the donor conference in Brussels on May 9 and 10? How does this one differ from the previous ones?

This conference is traditionally the main pledging event of the year for the Syrian people. What is different this year is that it takes place on the backdrop of an unprecedented military aggression directly in EU’s neighborhood. But we want to show to Syrian people that despite the Russian aggression against Ukraine, we remain committed to continue supporting also the Syrian people and host communities in neighboring countries, and we are not forgetting them. With the Brussels Conference this year, we want to ensure sustained international attention and support for them.

We have hosted the Brussels Conference since 2017. The objectives are to reassert the international community’s commitment towards Syrians and towards a negotiated political solution to the conflict in line with UN Security Council Resolution 2254, to continue mobilizing much needed financial support to meet the needs of Syrian refugees and their host communities in neighboring countries, and to provide a platform for dialogue with civil society.

2- Why did you not invite the Russian government to the Brussels conference?

As host of the Conference, we are inviting those partners who have a genuine interest to contribute to peace in the world and to help victims of conflict. Through its aggression on Ukraine, Russia has proven that it is not sharing this interest.

3- The conference comes after the European Union renewed economic sanctions against Damascus. Does it have any effect on Brussels conference?

These are two different things, they are not linked and are not in contradiction. The Conference aims to raise funds for the Syrian people – mainly the refugees and internally displaced. The sanctions target the regime for its continued violent repression against the civilian population. Our sanctions are a clear signal that the repressive policies of the Assad regime against the civilian population of Syria, including the expropriation of land for political purposes, as well as the use of chemical weapons, are considered unacceptable by the European Union. They are also sending a message to the supporters of the Syrian regime that their support to the regime would come at a cost.

EU sanctions are not targeted against the Syrian people, do not prohibit the export of food, medicines or medical equipment and a number of exceptions are foreseen for humanitarian purposes. This shows that we care for Syrian people and the Brussels Conference is only reinforcing this commitment to help them in any way we can.

4- The EU after last meeting in Brussels, have said that they are committed to the three No’s: no to contribution to the reconstruction, to lifting of the sanctions, no formulations [“normalization”?] without success of the political process in Syria. Are these conditions still valid?

The EU policy positions have not changed since the behavior of the Assad regime is not changing. The EU will not re-establish full diplomatic relations with Syria, we will not start working on reconstruction until a genuine and comprehensive political transition is firmly under way in accordance with UN Security Council Resolution 2254.

As long as there is no progress in the implementation of the relevant UN resolutions for Syria, the European Union will maintain its sanctions regime as an additional means of pressure on the Syrian regime to change its behavior.

At the same time, we will continue our large-scale humanitarian work in Syria and the region, in support of the Syrian people, wherever they reside as well as their host communities in neighboring countries. Since the beginning of the Syrian conflict in 2011, the European Union and its Member States have been the largest donors of humanitarian and resilience assistance to Syria and the region with € 27.4 billion.

5- Moscow and Damascus are asking to put money in “early recovery” projects. What's the EU position on this?

We do not work with the regime inside Syria, in line with our position on no relations with the Syrian regime and no reconstruction until a genuine and comprehensive political transition is firmly under way in accordance with UN Security Council Resolution 2254.

However, the European Union is supporting the Syrian people directly suffering from the conflict, to build their future. We are actively fostering local initiatives in Syria where EU parameters and red lines are respected. We are supporting and empowering civilians across the country, working on education, health, livelihoods, building social cohesion, demining. These activities implemented at grassroots level aim at addressing the current needs of the population while also preparing the ground for Syria’s future for all Syrians.

We are also supporting the restauration of a dialogue and social cohesion among Syrians inside Syria and the region after eleven years of conflict. Supporting the development of a strong civil society with a specific emphasis on Syrian women and youth is essential in this regard. This is also the reason why the Brussels Conferences put a strong emphasis on the dialogue with civil society. Together with the Syrian people, they are the actor of change for the future of Syria.

6- What is your position on the efforts of the UN Envoy to Syria Mr. Pedersen on Constitutional reforms and on his “step-for-step" proposal?

The European Union fully supports the efforts of UN Special Envoy Pedersen to make progress on all elements of UN Security Council Resolution 2254, including the work of the Constitutional Committee in Geneva and the Special Envoy’s “steps-for-steps” approach. We discussed this and other related issues at Ministerial level at the meeting of EU Foreign Affairs minister in January, which was also attended by UNSE Pedersen.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.